Session 1: Cardio-oncology Partnership:

Scope of the Field of Cardio – Oncology
Giuseppe Curigliano, European Institute of Oncology, Italy

A Cardio-Oncology Clinic in Israel – The RMC experience
Zaza Iakobishvili, Rabin Medical Center

In the Bottom of the Heart – Case presentation
Amos Levi, Rabin Medical Center

 

Session 2: Chemotherapy and Cardiotoxicity:

Telomere Shortening, Chemotherapy and Cardiotoxicity
Meir Lahav, Rabin Medical Center

Anthracycline Cardiotoxicity – Case presentation
Hadas Ofek, Rabin Medical Center
Prior Chemotherapy and Cardiotoxicity in Breast Cancer
David Geffen, Soroka Medical Center

Tyrosine Kinase Inhibitors and Cardiovascular Disease
Pia Raanani, Rabin Medical Center

 

Session 3: Cardiotoxicity – Chimera with a Thousand Faces:

Research Opportunities that Overlap Cardiology and Oncology
Giuseppe Curigliano, European Institute of Oncology, Milano, Italy

Defining Cardiotoxicity: Do we have all the answers?
Zaza Iakobishvili, Rabin Medical Center

Myocardial Infarction in a Young Childhood Hodgkin Lymphoma Survivor – Case Presentation
Uri Landes, Rabin Medical Center

MI in a Patient Treated with 5FU -Case Presentation
Michal Sarfati, Rabin Medical Center

Fluoropyrimidine Cardiotoxicity
Chiara Lestuzzi, National Cancer Institute CRO, Aviano, PN, Ita

 

Session 4: Defeat the Cancer, Save the Heart:

Anticancer Drug Induced QT Interval Prolongation – a Regulatory or a Clinical Problem?
Boaz Mendzelevski, BioClinica Inc, London, UK

Proposal for Israel Heart Society Position Paper on Cancer Treatment Cardiotoxicity
Michael Arad, Sheba Medical Center

Malignant Pericardial Effusion – Diagnosis and Management
Daliah Tsoref, Rabin Medical Center

AL Cardiac Amyloidosis – Case Presentation
Eli Muchtar, Rabin Medical Centerly

 

Session 5: Heart Failure and Cancer: New Paradigm?

Increased Risk of Cancer in Heart Failure
Tal Hasin, Shaare Zedek Medical Center